HBV
Good Results With Biktarvy in HIV–HBV Coinfection
At CROI 2025, Dr. Anchalee Avihingsanon and her colleagues reported Week 48 outcomes from the open-label extension ...
MARCH 18, 2025
Pharmacist Recommendations Improve Hepatitis B Screening in Oral Oncology Patients
The vast majority of providers accept pharmacist-initiated recommendations to screen for hepatitis B virus in ...
DECEMBER 4, 2024
Improving HBV Screening Before Switching to 2-Drug HIV Regimens
Implementation of a best-practice alert in the EHR led to a significant decrease in switches to two-drug ART among ...
NOVEMBER 15, 2024
Immigrants With Chronic HBV Are Vulnerable to Lapses in Antiviral Use
Due to multiple factors, immigrants living in the United States who have chronic hepatitis B virus (HBV) are ...
NOVEMBER 8, 2024
Proposed FDA Rule Could Enable POC Hepatitis B Testing
Recent steps by the FDA and NIH increase the likelihood of point-of-care testing for hepatitis B virus becoming ...
NOVEMBER 1, 2024
MASLD and HBV: How Concurrence May Paradoxically Protect and Worsen Disease
The prevalence of fatty liver disease has increased worldwide, and is particularly problematic among patients with ...
SEPTEMBER 11, 2024
HCV Elimination Program So Successful, Country of Georgia Tackles HBV
Program could serve as a model for others to tackle these viral diseases.
SEPTEMBER 6, 2024
‘Viral Hepatitis Is Not Gone—Not Yet’
About 1.2 million people around the world are infected with hepatitis B each year; the U.S. sees about 20,000 new ...
AUGUST 26, 2024
High Virologic Suppression Seen With DTG/3TC Among Patients With Reactive HBV Core Antibody
Dovato demonstrates high rates of virologic suppression among people living with HIV and who have reactive anti-HBc ...
JULY 23, 2024
Viral Hepatitis Infections Claim 3,500 Lives Every Day
The number of lives lost due to viral hepatitis is increasing, making it the second leading infectious cause of ...
APRIL 10, 2024
Protecting More Adults From HBV
With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against ...
JULY 19, 2023
Increasing The Number of People Protected Against HBV
With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against ...
JUNE 15, 2023
